30 Sep, 16:14 - Indian

SENSEX 84299.78 (-1.49)

Nifty 50 25810.85 (-1.41)

Nifty Bank 52978.1 (-1.59)

Nifty IT 41946.1 (-0.87)

Nifty Midcap 100 60153.8 (-0.38)

Nifty Next 50 77095.15 (-0.92)

Nifty Pharma 23281.2 (-1.01)

Nifty Smallcap 100 19179.65 (-0.32)

30 Sep, 16:14 - Global

NIKKEI 225 37919.55 (-4.80)

HANG SENG 21133.68 (2.43)

S&P 5789 (-0.25)

Login/Signup
LOGIN HERE
Cancel

Shalby Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 540797 | NSE Symbol : SHALBY | ISIN : INE597J01018 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
29-Jun-2024 08-Jul-2024 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2024 inter alia to consider and approve unaudited financial results for quarter ended June 30 2024 Outcome of Board Meeting Q1FY2024-25 Results-Unaudited Financials results For Q1FY2024-25 (As per BSE Announcement Dated on 08/07/2024)
17-May-2024 28-May-2024 Final Dividend Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2024 and recommendation of dividend for FY 2023-24 BM-Recommendation of Dividend (As Per BSE Announcement dated on 28.05.2024)
12-Mar-2024 12-Mar-2024 Acquisitions Acquisition of 100% equity shares of Healers Hospital Private Limited Update on acquisition of 100% Equity Stake in Healers Hospital Private Limited (As Per BSE Announcement Dated on 16.03.2024)
30-Jan-2024 07-Feb-2024 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2024 inter alia to consider and approve Unaudited Standalone and Consolidated financial results for quarter ended December 31 2023 and other business matters Financial results Q3 FY 2023-24 Unaudited standalone and consolidated Financial Results for quarter ended December 31, 2023 (As Per BSE Announcement dated on 07.02.2024)
18-Jan-2024 18-Jan-2024 Acquisitions Outcome of Board Meeting held on January 18, 2024 - Acquisition
19-Oct-2023 27-Oct-2023 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve Unaudited Standalone And Consolidated Financial Results For Quarter Ended September 30 2023 Financial Results for Quarter and Half Year ended September 30, 2023 Outcome of Board Meeting - Financial Results For Quarter and Half Year Ended September 30, 2023 (As Per BSE Announcement dated on 27.10.2023)
13-Jul-2023 20-Jul-2023 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial results for quarter ended June 30 2023 and other business matters Financial Results for quarter ended June 30, 2023 Outcome of Board Meeting for unaudited Financial Results for Quarter ended June 30, 2023 (As Per BSE Announcement Dated on 20.07.2023)
05-May-2023 18-May-2023 Accounts Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2023 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2023 recommendation of dividend for FY2022-23 and other business matters Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 ,inter alia, to consider and approve Audited financial results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2023, recommendation of dividend on equity shares for year ended March 31, 2023 and other business matters. (As Per BSE Announcement Dated on 09.05.2023) Audited Financial Results for FY 2022-23 Board recommended of Rs. 1.20 per equity share of Rs. 10/- each for financial year 2022-23 Outcome of Board Meeting held on 18th May 2023 Appointment of Mr. Ashok Bhatia and Mr. Vijay Kedia as Non-Executive and Independent Directors, subject to approval of members at the ensuing Annual General Meeting Appointment of Mr. Amit Pathak, as Chief Financial Officer w.e.f. May 19, 2023 Re-appointment of Statutory Auditors for second term of 5 years, subject to approval of members at ensuing annual general meeting (As Per BSE Announcement Dated on 18/05/2023)
05-Jan-2023 17-Jan-2023 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for quarter ended December 31 2022. Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('the SEBI LODR') (As Per BSE Announcement dated on 17.01.2023)
20-Dec-2022 20-Dec-2022 Subsidiary Company Conversion of Loan given by Mars Medical Devices Limited (MMDL) (WOS of Shalby Ltd) to Shalby Advanced Technologies, Inc. USA (WOS of MMDL) into Preferred Stock and Common Stock
11-Oct-2022 18-Oct-2022 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2022 inter alia to consider and approve financial statements for quarter and half year ended September 2022 - Intimation under regulation 29(1) of SEBI (LODR) Reg 2015. Outcome of Board Meeting held on 18-Oct-2022 for approval of standalone and consolidated financial statements for the quarter and half year ended September 30, 2022 (As per BSE Announcement Dated on 18/10/2022)
18-Jul-2022 26-Jul-2022 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2022 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results for quarter ended June 30 2022. Considered and Approved Unaudited Standalone and Consolidated financial results of the Company for quarter ended June 30, 2022. Unaudited Standalone and Consolidated financial results of the Company for quarter ended June 30, 2022 (As Per BSE Announcement dated on 26.07.2022)
14-May-2022 25-May-2022 Accounts Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 inter alia to consider and approve Board Meeting Intimation for approval of Audited Standalone and Consolidated Financial Results for quarter and year ended March 31 2022 and recommendation of dividend for FY 2021-22 Shalby Board recommend dividend of Rs. 1.00 per equity share of Rs. 10.00 Outcome of Board Meeting held on 25-May-2022 to consider Audited Standalone and Consolidated financial statements for the quarter and year ended March 31, 2022 and Dividend (As per BSE Announcement Dated on 25/5/2022)
27-Jan-2022 02-Feb-2022 Quarterly Results Shalby Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015 we hereby inform you that a meeting of Board of Directors of Shalby Limited is scheduled to be held on Wednesday February 2 2022 inter- alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2021. As informed earlier vide our letter no. Shalby/SE/2021-22/83 dated December 30 2021 the Trading Window for dealing in securities of the Company for all insiders was closed from January 1 2022 and shall remain closed till 48 hours after the announcement of the financial results on February 2 2022. Outcome of Board Meeting We Wish to inform you that, pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), the Board of Directors of the Company, based on recommendation of Nomination and Remuneration Committee and Audit Committee, at their respective Meetings held today has approved the appointment of Mr. Venkat Parasuraman, as Chief Financial Officer and Key Managerial Personnel of the Company w.e.f. February 2, 2022. Disclosure Under Regulation 30 (5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 02.02.2022) With reference to outcome of Board Meeting as submitted vide above referred letter, please find attached herewith financials statement along with Segment wise information, which was missing in our earlier submission. Please note that we have already uploaded the same in XBRL mode on NSE - NEAPs and BSE Listing Centre on February 2, 2022. There is no change in any of the financial figures submitted earlier. (As Per BSE Announcement Dated on 04/02/2022)
20-Oct-2021 26-Oct-2021 Quarterly Results Quarterly Results Outcome of Board Meeting - Unaudited financial results for quarter and half year ended 30th September 2021. Unaudited Financial Results for quarter and half year ended 30th September 2021 (As per BSE Announcement Dated on 26/10/2021)
1 2